Richard Wooster

Subtype and pathway specific responses to anticancer compounds in breast cancer

Laura M. Heiser, Anguraj Sadanandam, Wen‐Lin Kuo et al. · Proceedings of the National Academy of Sciences · 2011 · 501 citations

Drug Target, Breast Oncology, Chemoprevention Strategy +17

Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases

Fawn Qian, Stefan Engst, Peiwen Yu et al. · Cancer Research · 2009 · 336 citations

Tumor Cell Growth, Novel Inhibitor, Vegf Receptor 2 +16

Antitumor activity of an allosteric inhibitor of centromere-associated protein-E

Kenneth W. Wood, Latesh Lad, Lusong Luo et al. · Proceedings of the National Academy of Sciences · 2010 · 252 citations · Full text

Antitumor Activity, Cenp-e Motor Activity, Molecular Biology +18

Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells

Julia Billiard, Jennifer B. Dennison, Jacques Briand et al. · Cancer & Metabolism · 2013 · 231 citations · Full text

Analysis of glutamine dependency in non-small cell lung cancer

A. Pieter J. van den Heuvel, Junping Jing, Richard Wooster et al. · Cancer Biology & Therapy · 2012 · 211 citations · Full text

Metabolic Remodeling, Cancer Biology, Tumor Biology +16